| Literature DB >> 35887748 |
Chenglei Zhao1, Chenxi Zhao1, Yunfeng Li1, Minmin Zhao1, Lin Wang1, Jiawei Guo1, Longhai Zhang1, Yuliang Sun1, Xintong Ye1, Wenfei Zhu1.
Abstract
BACKGROUND: Aging and physical inactivity are associated with declines in physical fitness and cognitive function. Active video games have proven to be beneficial for the physical health of older adults, but the exact effect of active video games on physical fitness and cognitive function was still unclear. Based on self-determination theory (SDT), which is a widely used theory of healthy behavior change, this study aimed to explore the effects of an active video game intervention on fitness and cognitive function in older adults.Entities:
Keywords: active video game; cognitive function; older adults; physical fitness
Year: 2022 PMID: 35887748 PMCID: PMC9321167 DOI: 10.3390/jcm11143984
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Figure 1Study flow chart; MMSE: Mini-Mental State Examination.
Figure 2Motivational states and external intervention intensity changes.
Baseline demographic characteristics and screening values of the analyzed participants.
| Index | IG | CG | Total | t/χ2 |
| |
|---|---|---|---|---|---|---|
| Number of people | 22 | 16 | 38 | |||
| Age, M (SD) | 65.64 (4.2) | 65.75 (3.24) | 65.68 (3.78) | −0.90 | 0.929 | |
| Female (%) | 14 (63.6) | 10 (62.5) | 24 (63.20) | 0.01 | 0.943 | |
| Mini mental screener examination, M (SD) | 29 (1) | 28.69 (1.1) | 28.87 (1.07) | 0.89 | 0.381 | |
| Education (%) | 5.80 | 0.215 | ||||
| Primary school | 1 (4.5) | 1 (16.3) | 2 (5.3) | |||
| Junior high school | 8 (36.4) | 2 (12.5) | 10 (26.3) | |||
| High school | 5 (22.7) | 7 (43.8) | 12 (31.6) | |||
| college | 6 (27.3) | 2 (12.5) | 8 (21.1) | |||
| Undergraduate course | 2 (9.1) | 5 (25) | 6 (15.8) | |||
| Smoking (%) | 1 (4.5) | 1 (6.3) | 2 (5.3) | 0.05 | 0.816 | |
| Alcohol consumption (%) | 4 (18.2) | 1 (6.3) | 5 (13.2) | 1.15 | 0.283 | |
| Industry engaged (%) | 1.72 | 0.887 | ||||
| professional | 6 (27.3) | 4 (25) | 10 (26.3) | |||
| industrial | 1 (4.5) | 2 (12.5) | 3 (7.9) | |||
| administrative | 2 (9.1) | 1 (06.3) | 3 (7.9) | |||
| Agriculture | 2 (9.1) | 1 (06.3) | 3 (7.9) | |||
| general | 1 (4.5) | 0 (00.0) | 1 (2.6) | |||
| other | 10 (45.5) | 8 (50.0) | 18 (47.4) | |||
| Sports injury (%) | 6.00 | 0.199 | ||||
| knee | 3 (13.6) | 7 (43.8) | 10 (26.3) | |||
| vertebral | 5 (22.7) | 1 (6.3) | 6 (15.8) | |||
| diverse | 1 (4.5) | 0 | 1 (2.6) | |||
| other | 3 (13.6) | 1 (6.3) | 4 (10.5) | |||
| without | 10 (45.5) | 7 (43.8) | 17 (44.7) | |||
| Medication (%) | 11 (50) | 5 (31.3) | 16 (42.1) | 1.34 | 0.248 | |
| Chronic diseases (%) | 0.48 | 0.923 | ||||
| One of the three tenors | 4 (18.2) | 4 (25.0) | 8 (21.1) | |||
| diverse | 4 (18.3) | 2 (12.5) | 6 (15.8) | |||
| other | 5 (22.7) | 3 (18.8) | 8 (21.1) | |||
| without | 9 (40.9) | 7 (43.8) | 16 (42.1) | |||
| Vision and hearing problems (%) | 8.60 | 0.072 | ||||
| myopia | 4 (18.2) | 0 | 4 (10.5) | |||
| presbyopia | 2 (9.1) | 4 (25.5) | 6 (15.8) | |||
| diverse | 0 | 2 (12.5) | 2 (5.3) | |||
| other | 2 (9.1) | 0 | 2 (5.3) | |||
| without | 14 (63.6) | 10 (62.5) | 24 (63.2) | |||
| Walking (min/day) | 57.0 (44.4) | 43.5 (41.1) | 51.3 (43.0) | 0.95 | 0.347 | |
| Moderate physical activity (min/day) | 52.6 (88.9) | 83.7 (83.9) | 65.8 (87.1) | −1.09 | 0.283 | |
| Vigorous physical activity (min/day) | 14.2 (31.7) | 8.2 (16.7) | 11.7 (26.3) | 0.68 | 0.499 | |
| Total physical activity (min/day) | 123.8 (97.2) | 135.5 (103.1) | 128.7 (98.5) | −0.36 | 0.724 |
Notes: IG: intervention group; CG: control group; SD: Standard deviation.
Figure 3Pre- and post-intervention physical activity (including walking and moderate-to-vigorous physical activity, F = 3.798, p = 0.059, d = 0.38).
Baseline (0 weeks), post-test (12 weeks) change for physical fitness variables.
| IG ( | CG ( | 0 Weeks vs. 12 Weeks | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Index | 0 Weeks | 12 Weeks | 0 Weeks | 12 Weeks | F |
| d | Effect Size | ||||
|
| ||||||||||||
| BMI, kg/m2 | 23.84 | (2.8) | 23.33 | (2.58) | 23.65 | (3.69) | 23.86 | (3.54) | 9.814 | 0.004 * | −0.93 | L |
| Body fat rate, % | 24.78 | (8.57) | 25.95 | (7.16) | 25.13 | (6.75) | 26.14 | (6.78) | 0.070 | 0.793 | 0.03 | - |
| Systolic blood pressure, mmhg | 126.18 | (15.13) | 127.23 | (16.14) | 122.30 | (12.90) | 132.10 | (8.90) | 5.280 | 0.028 * | −0.68 | M |
| Diastolic blood pressure, mmhg | 75.68 | (8.81) | 74.91 | (6.89) | 70.80 | (10.40) | 77.30 | (8.20) | 6.418 | 0.016 * | −0.86 | L |
| Vital capacity, mL | 2570.82 | (785.61) | 2762.18 | (991.1) | 2646.60 | (736.4) | 2556.70 | (844.9) | 4.708 | 0.038 * | 0.67 | M |
| Grip strength, kg | 28.31 | (8.20) | 27.76 | (9.04) | 30.30 | (9.1) | 28.70 | (9.0) | 0.647 | 0.427 | 0.39 | S |
| Sitting forward, cm | 5.68 | (11.94) | 5.96 | (11.13) | 5.20 | (11.0) | 6.90 | (10.5) | 0.932 | 0.342 | −0.32 | S |
| Reaction time, s | 0.56 | (0.09) | 0.58 | (0.07) | 0.60 | (0.1) | 0.60 | (0.1) | 0.099 | 0.756 | 0.25 | S |
|
| ||||||||||||
| Total length of the swing, mm (open Eyes) | 209.83 | (51.81) | 205.12 | (60.44) | 213.42 | (47.65) | 226.12 | (49.62) | 1.237 | 0.274 | −0.22 | S |
| Total velocity of the swing, mm/s (open Eyes) | 10.49 | (2.59) | 10.26 | (3.02) | 10.67 | (2.38) | 11.31 | (2.48) | 1.231 | 0.275 | −0.25 | S |
| Total area of swing, mm × s (open Eyes) | 212.90 | (124.10) | 181.63 | (105.58) | 194.34 | (65.61) | 202.78 | (69.23) | 1.097 | 0.303 | −0.33 | S |
| Total length of the swing, mm (Closed Eyes) | 271.48 | (82.40) | 230.85 | (74.57) | 257.31 | (80.44) | 288.58 | (95.86) | 3.728 | 0.062 | −0.62 | M |
| Total velocity of the swing, mm/s (Closed Eyes) | 13.57 | (4.12) | 11.55 | (3.73) | 12.87 | (4.02) | 14.43 | (4.77) | 3.740 | 0.062 | −0.62 | M |
| Total area of swing, mm × s (Closed Eyes) | 271.18 | (141.13) | 203.92 | (116.03) | 216.80 | (93.30) | 269.10 | (142.60) | 2.920 | 0.097 | −0.70 | M |
|
| ||||||||||||
| Total bilirubin, μmol/L | 16.87 | (3.54) | 13.42 | (2.22) | 16.29 | (3.73) | 13.82 | (3.54) | 0.666 | 0.421 | −0.31 | S |
| Direct bilirubin, μmol/L | 7.02 | (1.52) | 3.94 | (1.12) | 6.84 | (1.25) | 4.30 | (1.56) | 1.632 | 0.211 | −0.36 | S |
| Indirect bilirubin, μmol/L | 10.17 | (2.63) | 9.55 | (1.88) | 9.47 | (2.66) | 9.53 | (2.26) | 0.182 | 0.673 | −0.30 | S |
| Glutamic-pyruvic transaminase, μ/L | 24.41 | (18.86) | 25.79 | (13.25) | 27.78 | (33.88) | 26.00 | (12.78) | 0.261 | 0.613 | 0.16 | - |
| Glutamic oxalacetic transaminase, μ/L | 22.85 | (11.48) | 21.96 | (5.65) | 19.47 | (4.82) | 22.22 | (5.02) | 0.075 | 0.786 | −0.37 | S |
| Glucose, mmol/L | 4.80 | (0.75) | 5.15 | (0.85) | 4.87 | (0.60) | 5.14 | (0.94) | 0.500 | 0.485 | 0.14 | - |
| Urea, mmol/L | 5.33 | (1.28) | 6.74 | (1.58) | 5.55 | (1.24) | 6.38 | (1.27) | 2.780 | 0.105 | 0.51 | M |
| Creatinine, μmol/L | 69.92 | (14.95) | 73.36 | (12.61) | 72.80 | (10.84) | 73.56 | (11.46) | 1.062 | 0.310 | 0.33 | S |
| Uric acid, μmol/L | 331.86 | (97.26) | 279.55 | (73.84) | 346.83 | (80.59) | 309.19 | (69.49) | 1.691 | 0.203 | −0.29 | S |
| Total cholesterol, mmol/L | 5.50 | (0.96) | 5.40 | (0.97) | 5.30 | (1.17) | 4.94 | (0.91) | 7.020 | 0.012 | 0.37 | S |
| Triglyceride, mmol/L | 1.39 | (0.58) | 1.49 | (0.73) | 1.43 | (0.68) | 1.56 | (0.81) | 0.082 | 0.777 | −0.05 | - |
| High density cholesterol, mmol/L | 1.59 | (0.38) | 1.51 | (0.38) | 1.62 | (0.34) | 1.43 | (0.35) | 1.964 | 0.171 | 0.40 | S |
| Low density cholesterol, mmol/L | 3.35 | (0.73) | 3.23 | (0.78) | 3.10 | (0.79) | 2.78 | (0.53) | 9.469 | 0.004 | 0.34 | S |
| Insulin, μ/mL | 6.69 | (3.51) | 5.87 | (2.93) | 6.68 | (2.37) | 6.19 | (2.12) | 0.001 | 0.977 | −0.14 | - |
Note: IG: intervention group; CG: control group; BMI: Body Mass Index; SD: Standard deviation; *: p < 0.05; The magnitudes of the effect sizes were categorized as N (none): (0 ≤ Cohen’s d < 0.20), S (small): (0.20 ≤ Cohen’s d < 0.50), M (medium): (0.50 ≤ Cohen’s d < 0.80), or L (large): (Cohen’s d ≥ 0.80).
Changes from baseline (0 weeks) to posttest (12 weeks) in the cognitive function variables.
| IG ( | CG ( | 0 Weeks vs. 12 Weeks | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Index | 0 Weeks | 12 Weeks | 0 Weeks | 12 Weeks | F |
| d | Effect Size | ||||
| Symbol search | 29.14 | (6.33) | 29.91 | (7.00) | 30.10 | (7.30) | 30.00 | (7.20) | 0.103 | 0.751 | 0.19 | - |
| Operations span | 3.49 | (2.00) | 4.09 | (4.09) | 5.10 | (3.20) | 5.10 | (3.10) | 0.050 | 0.825 | 0.25 | S |
| Portrait memory | 19.50 | (6.06) | 19.59 | (7.58) | 20.70 | (9.20) | 18.20 | (8.80) | 1.413 | 0.243 | 0.38 | S |
| Spatial cognition | 5.00 | (3.04) | 5.86 | (2.80) | 4.90 | (2.30) | 3.90 | (2.90) | 8.261 | 0.007 * | 0.72 | M |
| Similar tests | 33.41 | (12.09) | 32.91 | (14.31) | 31.40 | (14.50) | 36.00 | (11.70) | 0.847 | 0.364 | −0.46 | S |
Note: IG: intervention group; CG: control group; SD: Standard deviation; *: p < 0.05; The magnitudes of the effect sizes were categorized as N (none): (0 ≤ Cohen’s d < 0.20), S (small): (0.20 ≤ Cohen’s d < 0.50), M (medium): (0.50 ≤ Cohen’s d < 0.80), or L (large): (Cohen’s d ≥ 0.80).